Gastroesophageal variceal haemorrhage - New achievements in pathophysiology;Gastrooesophagealis varixvérzés - Újdonságok a patofiziológia terén

Orvosi Hetilap

Volumn 147, Issue 7, 2006, Pages 309-314

  Papp, Mária ^a,b   Udvardy, Miklós ^b   Zsuzsanna, Vitális ^a   Tornai, István ^a   Altorjay, István ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b Hematológiai Tanszék ^*  (Hungary)

Author keywords

Bacterial infection; Gastroesophageal variceal haemorrhage; Haemostasis; Portal hypertension

Indexed keywords

ANTIBIOTIC AGENT; ENDOTOXIN; TERLIPRESSIN; ANTIHYPERTENSIVE AGENT; DRUG DERIVATIVE; LYPRESSIN; VASOCONSTRICTOR AGENT;

BACTERIAL INFECTION; BACTERIAL OVERGROWTH; DISEASE SEVERITY; ENDOTOXEMIA; ESOPHAGUS VARICES BLEEDING; HEMOSTASIS; HUMAN; HYPOTHESIS; INTESTINAL DYSMOTILITY; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIVER CIRRHOSIS; LIVER FUNCTION; MORTALITY; PATHOPHYSIOLOGY; PERIPHERAL CIRCULATION; PORTAL VEIN BLOOD FLOW; PORTAL VEIN BLOOD PRESSURE; PRESSURE GRADIENT; PROPHYLAXIS; REVIEW; UPPER GASTROINTESTINAL BLEEDING; VEIN RUPTURE; VEIN WALL; VENOUS PRESSURE; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; RISK FACTOR; RUPTURE;

ANTIHYPERTENSIVE AGENTS; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; LYSINE VASOPRESSIN; RISK FACTORS; RUPTURE, SPONTANEOUS; VASOCONSTRICTOR AGENTS;

EID: 34249691895     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Amitrano, L., Guardascione, M. A., Brancaccio, V. és mtsai: Coagulation disorders in liver diseases. Semin. Liver Dis., 2002, 22, 83-96.
2. Ben-Ari, Z., Cardin, F., McCormick, A. P. és mtsai: A predictive model for failure to control bleeding during acute variceal haemorrhage. J. Hepatol., 1999, 31, 443-450.
3. Benavides, J., Fernandez, N., Colombato, L.: Further evidence linking bacterial infection and upper G.I. bleeding in cirrhosis. Results from a large multicentric prospective survey in Argentina. J. Hepatol., 2003, 38 (Suppl. 2.), A 176.
4. Bernard, B., Cadranel, J. F., Valla, D. és mtsai: Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology, 1995, 108, 1828-1834.
5. Bernard, B., Grangé, J. D., Khac, E. N. és mtsai: Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology, 1999, 29, 1655-1661.
6. Borzio, M., Salerno, F., Piantoni L.: Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig. Liver Dis., 2001, 33, 41-48.
7. Bosch, J., Abraldes, J. G.: Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Semin. Hematol., 2004, 41 (Suppl. 1.), 8-12.
8. Brett, B. T., Hayes, P. C., Jalan, R.: Primary prophylaxis of variceal bleeding in cirrhosis. Eur. J. Gastroenterol. Hepatol., 2001, 13, 349-358.
9. Chau, T. N., Chan, Y. W., Patch, D. és mtsai: Thrombelastographic changes and early rebleeding in cirrhotic patients with variceal bleeding. Gut, 1998, 43, 267-271.
10. Chelarescu, O., Chelarescu, D., Tircoveanu, E. és mtsai: Propranolol administration on post surgical infections in cirrhotic patients. J. Hepatol., 2003, 38 (Suppl. 2.), A173.
11. D'Amico, G., Luca, A.: Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding. Baillieres Clin. Gastroenterol., 1997, 11, 243-256.
12. de Franchis, R.: Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J. Hepatol., 2005, 43, 167-76.
13. de Franchis, R., Primignani, M.: Natural history of portal hypertension in patients with cirrhosis. Clin. Liver Dis., 2001, 5, 645-663.
14. de Franchis, R.: Updating consensus in portal hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J. Hepatol., 2000, 33, 846-852.
15. Fernandez, M., Vizzutti, F., Garcia-Pagan, J. C. és mtsai: Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice. Gastroenterology, 2004, 126, 886-894.
16. Garden, O. J., Motyl, H., Gilmour, W. H. és mtsai: Prediction of outcome following acute variceal haemorrhage. Br. J. Surg., 1985, 72, 91-95.
17. Goulis, J., Armonis, A., Patch, D. és mtsai: Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage. Hepatology, 1998, 27, 1207-1212.
18. Goulis, J., Patch, D., Burroughs, A. K.: Bacterial infection in the pathogenesis of variceal bleeding. Lancet, 1999, 353, 139-142.
19. Grignani, G., Maiolo, A: Cytokines and hemostasis. Haematologica, 2000, 85, 967-972.
20. Hoshino, S., Shinoura, S., Akamine, H. és mtsai: Effect of propranolol for the prevention of spontaneous bacterial peritonitis. Am. J. Gastroenterol., 2000, 95, A349.
21. Hou, M. C., Lin, H. C., Liu. T. T.: Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology, 2004, 39, 746-753.
22. Janssen, H. L., Wijnhoud, A., Haagsma, E. B. és mtsai: Extrahepatic portal vein thrombosis: aetiology and determination of survival. Gut, 2001, 49, 720-724.
23. Joshi, N. G., Stanley, A. J.: Update on the management of variceal bleeding. Scott. Med. J., 2005, 50, 5-10.
24. Kamath, P. S.: Esophageal variceal bleeding: primary prophylaxis. Clin. Gastroenterol. Hepatol., 2005, 3, 90-93.
25. McCormick, P. A., O'Keefe, C.: Improving prognosis following a first variceal haemorrhage over four decades. Gut, 2001, 49, 682-685.
26. McKee, R. F., Hodson, S., Dawes, J. és mtsai: Plasma concentrations of endogenous heparinoids in portal hypertension. Gut, 1992, 33, 1549-1552.
27. Moitinho, E., Escorsell, A., Bandi, J. C. és mtsai: Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology, 1999, 117, 626-631.
28. Montalto, P., Vlachogiannakos, J., Cox, D. J. és mtsai: Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J. Hepatol., 2002, 37, 463-470.
29. Nevens, F., Bustami, R., Scheys, I. és mtsai: Variceal pressure is a factor predicting the risk of a first variceal bleeding: prospective cohort study in cirrhotic patients. Hepatology, 1998, 27, 15-19.
30. Papatheodoridis, G. V., Patch, D., Webster, G. J. és mtsai: Infection and hemostasis in decompensated cirrhosis: a prospective study using thrombelastography. Hepatology, 1999, 29, 1085-1090.
31. Papp, M., Udvardy, M., Palatka, K. és mtsai: Inflammation and agressive proteolytic enzymes: myeloperoxidase and matrix metalloproteinase-9 - Do they play a role in acute variceal bleeding? Gut, 2004, 53 (Suppl. VI.), A259.
32. Patch, D., Armonis, A., Sabin, C. és mtsai: Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut, 1999, 44, 264-269.
33. Plessier, A., Denninger, M., Durand, F. és mtsai: Marked decreases in protein C and antithrombin III activities in patients with cirrhosis and severe sepsis. J. Hepatol., 2002, 36(Suppl. 1), A628.
34. Plevris, J. N., Dhariwal, A., Elton, R. A. és mtsai: The platelet count as a predictor of variceal hemorrhage in primary biliary cirrhosis. Am. J. Gastroenterol., 1995, 90, 959-961.
35. Polio, J., Groszmann, R. J.: Hemodynamic factors involved in the development and rupture of esophageal varices: a pathophysiologic approach to treatment. Semin. Liver Dis., 1986, 6, 318-331.
36. Prediction of the first variceal haemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N. Eng. J. Med., 1988, 319, 983-989.
37. Primignani, M., Dell'Era, A., Carnevale, P.: Fibrinolytic and hemostatic abnormalities in gastroesophageal variceal bleeding in cirrhotic patients. J. Hepatol., 2000, 32 (Suppl. 2.), A65.
38. Sharara, A. I., Rockey, D. C.: Gastroesophageal variceal hemorrhage. N. Engl. J. Med., 2001, 345, 669-681.
39. Soares-Weiser, K., Brezis, M., Tur-Kaspa, R.: Antibiotic prophylaxis of bacterial infections in cirrhotic inpatients: a meta-analysis of randomized controlled trials. Scand. J. Gastroenterol., 2003, 38, 193-200.
40. Thalheimer, U., Triantos, C., Samonakis, D. és mtsai: Endogenous heparinoids in acute variceal bleeding. Gut, 2005, 54, 310-311.
41. Thalheimer, U., Triantos, C. K., Samonakis, D. N. és mtsai: Infection, coagulation, and variceal bleeding in cirrhosis. Gut, 2005, 54, 556-563.
42. Violi, F., Ferro, D., Basili, S. és mtsai: Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis. Gastroenterology, 1995, 109, 531-539.
43. Vivas, S., Rodriguez, M., Palacio, M. A. és mtsai: Presence of bacterial infection in bleeding cirrhotic patients is independently associated with early mortality and failure to control bleeding. Dig. Dis. Sci., 2001, 46, 2752-2757.
44. Vorobioff, J., Groszmann, R. J., Picabea, E. és mtsai: Prognostic value of hepatic venous pressure gradient measurements in alcoholic cirrhosis: a 10-year prospective study. Gastroenterology, 1996, 111, 701-709.
45. Wolf, D. C.: The management of variceal bleeding: past, present and future. Mt. Sinai J. Med., 1999, 66, 1-13.
46. Yin, Z. H., Liu, X. Y., Huang, R. L. és mtsa: Expression of TNF-alpha and VEGF in the esophagus of portal hypertensive rats. World J. Gastroenterol., 2005, 11, 1232-1236.
47. Zambruni, A., Thalheimer, U., Coppell, J. és mtsai: Endogenous heparin-like activity detected by anti-Xa assay in infected cirrhotic and non-cirrhotic patients. Scand. J. Gastroenterol., 2004, 39, 830-836.